FDA warns that popular hair loss drug has been linked to erectile dysfunction, brain fog and even suicidal thoughts
The FDA issued a public alert on Tuesday concerning generic versions of a widely-used hair loss drug that is frequently distributed by popular telehealth brands like Hims and Keeps. The agency cited 32 reports of adverse events that involved compounded topical finasteride products, which are “potentially putting consumers at risk.” These events include “erectile dysfunction, … Read more